Flonase Users Seek Sanctions For Foes Of $35M Antitrust Deal

Law360, New York (May 24, 2013, 2:42 PM EDT) -- Flonase purchasers urged a Pennsylvania federal court Thursday to sanction objectors to a $35 million class action settlement of allegations that GlaxoSmithKline PLC improperly delayed market entry of a generic nasal spray, saying the two objectors and their attorneys ignored a court order.

A group of indirect purchasers of Flonase filed a motion for sanctions against James Payton and Jill Jan — putative class members who lodged objections to a proposed settlement of antitrust claims brought against GSK — as well as attorney Darrell Palmer and...
To view the full article, register now.